Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Crowley started her career at Bayer Corporation in 1992, holding various positions providing leadership of clinical research and project management prior to completing her tenure there as the Director of Global Study Audit Management, assuring the highest standards for program execution.
He rose to Professor in the Departments of Medicine and Cell and Molecular Biology at the Uniformed Services University for the Health Sciences in Bethesda, Maryland before assuming his current position as of February 1, 1999.
Joseph Schlessinger has been the William H. Prusoff Professor and Chairman of the Department of Pharmacology at Yale University School of Medicine since 2001.
Conrad has been a director of Celldex since March 2004.
Marucci was appointed President and Chief Executive Officer of Celldex in September 2008 and as a director of Celldex in December 2008.
Crowley joined Celldex in 2009 as Vice President, Clinical Development.
Marucci is a member of the Board of Trustees of BioNJ Inc. and also served as its Treasurer through 2010.
Doctor Pepin joined Celldex in July 2011 as Senior Vice President and Chief Business Officer.
He joined Celldex in 2012 as Vice President of Commercial Operations.
Marino has served as a member of the board of directions of Onconova Therapeutics, Inc., a publicly held biopharmaceutical company, since July 2015 and currently serves as Chairman of the Board.
Shoos is currently a consultant in international blood safety and since November 2015, Ms.
Jimenez joined Celldex in 2016 as Vice President, Law and Compliance, serving as the Company’s chief counsel and compliance officer as well as providing executive leadership of information technology.
Brownlie has been a director of Celldex since June 2017.
Doctor Heath-Chiozzi joined Celldex in October 2017 as Senior Vice President, Regulatory Affairs.
Shoos was appointed Chair of the Board of Directors of Celldex in June 2019.
Doctor Young joined Celldex in July 2019 as Senior Vice President and Chief Medical Officer.
Rate how well Celldex Therapeutics lives up to its initial vision.
Do you work at Celldex Therapeutics?
Is Celldex Therapeutics' vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Acadia Pharmaceuticals | 1993 | $957.8M | 570 | 107 |
| Puma Biotechnology | 2010 | $230.5M | 265 | 7 |
| ImmunoCellular Therapeutics | 2006 | $1.6M | 4 | - |
| Amyris | 2003 | $269.8M | 595 | - |
| Zyomyx | 1998 | $840,000 | 5 | - |
| Emergent BioSolutions | 1998 | $1.6B | 1,834 | 11 |
| Morphotek | 2000 | $4.8M | 1 | - |
| T2 Biosystems | 2006 | $7.2M | 182 | - |
| ABC Laboratories | 1968 | $72.0M | 3,000 | 3 |
| Micell Technologies | 1995 | $3.1M | 14 | - |
Zippia gives an in-depth look into the details of Celldex Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Celldex Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Celldex Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Celldex Therapeutics. The data presented on this page does not represent the view of Celldex Therapeutics and its employees or that of Zippia.
Celldex Therapeutics may also be known as or be related to CELLDEX THERAPEUTICS INC., Celldex Therapeutics, Celldex Therapeutics Inc, Celldex Therapeutics, Inc. and Celldex Therapeutics, Inc. (Old).